WallStreetZenWallStreetZen

NASDAQ: CCCC
C4 Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CCCC

Based on 3 analysts offering 12 month price targets for C4 Therapeutics Inc.
Min Forecast
$8.00+33.33%
Avg Forecast
$14.00+133.33%
Max Forecast
$20.00+233.33%

Should I buy or sell CCCC stock?

Based on 3 analysts offering ratings for C4 Therapeutics Inc.
Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CCCC stock forecasts and price targets.

CCCC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-06
lockedlocked$00.00+00.00%2024-05-09
lockedlocked$00.00+00.00%2024-05-09

1 of 1

Forecast return on equity

Is CCCC forecast to generate an efficient return?
Company
-47.71%
Industry
-664.61%
Market
50.01%
CCCC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CCCC forecast to generate an efficient return on assets?
Company
-30.93%
Industry
27.48%
CCCC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CCCC earnings per share forecast

What is CCCC's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
-$1.57
Avg 2 year Forecast
-$1.62
Avg 3 year Forecast
-$1.59

CCCC revenue forecast

What is CCCC's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$25.7M-12.66%
Avg 2 year Forecast
$26.7M-9.12%
Avg 3 year Forecast
$28.0M-4.63%
CCCC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CCCC revenue growth forecast

How is CCCC forecast to perform vs Biotechnology companies and vs the US market?
Company
-1.63%
Industry
34.55%
Market
9.39%
CCCC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CCCC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CCCC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CCCC$6.00$14.00+133.33%Buy
ABSI$3.65$8.40+130.14%Strong Buy
OPT$3.10$12.00+287.10%Buy
GHRS$8.14$36.67+350.45%Strong Buy
XERS$2.86$4.67+63.18%Strong Buy
View Top Biotech Stocks

C4 Therapeutics Stock Forecast FAQ

Is C4 Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CCCC) stock is to Buy CCCC stock.

Out of 3 analysts, 1 (33.33%) are recommending CCCC as a Strong Buy, 1 (33.33%) are recommending CCCC as a Buy, 1 (33.33%) are recommending CCCC as a Hold, 0 (0%) are recommending CCCC as a Sell, and 0 (0%) are recommending CCCC as a Strong Sell.

If you're new to stock investing, here's how to buy C4 Therapeutics stock.

What is CCCC's earnings growth forecast for 2024-2026?

(NASDAQ: CCCC) C4 Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.25%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.61%.

C4 Therapeutics's earnings in 2024 is -$107,868,000.On average, 4 Wall Street analysts forecast CCCC's earnings for 2024 to be -$108,686,928, with the lowest CCCC earnings forecast at -$117,874,180, and the highest CCCC earnings forecast at -$101,233,119. On average, 5 Wall Street analysts forecast CCCC's earnings for 2025 to be -$112,188,484, with the lowest CCCC earnings forecast at -$131,741,731, and the highest CCCC earnings forecast at -$95,686,099.

In 2026, CCCC is forecast to generate -$110,247,027 in earnings, with the lowest earnings forecast at -$155,316,567 and the highest earnings forecast at -$92,219,211.

What is CCCC's revenue growth forecast for 2024-2026?

(NASDAQ: CCCC) C4 Therapeutics's forecast annual revenue growth rate of -1.63% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.55%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.39%.

C4 Therapeutics's revenue in 2024 is $29,378,000.On average, 5 Wall Street analysts forecast CCCC's revenue for 2024 to be $1,779,137,404, with the lowest CCCC revenue forecast at $1,040,066,295, and the highest CCCC revenue forecast at $2,377,938,239. On average, 3 Wall Street analysts forecast CCCC's revenue for 2025 to be $1,851,318,005, with the lowest CCCC revenue forecast at $1,414,559,499, and the highest CCCC revenue forecast at $2,080,132,590.

In 2026, CCCC is forecast to generate $1,942,635,826 in revenue, with the lowest revenue forecast at $1,216,946,903 and the highest revenue forecast at $2,551,629,310.

What is CCCC's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CCCC) forecast ROA is -30.93%, which is lower than the forecast US Biotechnology industry average of 27.48%.

What is CCCC's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CCCC price target, the average CCCC price target is $14.00, with the highest CCCC stock price forecast at $20.00 and the lowest CCCC stock price forecast at $8.00.

On average, Wall Street analysts predict that C4 Therapeutics's share price could reach $14.00 by Aug 6, 2025. The average C4 Therapeutics stock price prediction forecasts a potential upside of 133.33% from the current CCCC share price of $6.00.

What is CCCC's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: CCCC) C4 Therapeutics's current Earnings Per Share (EPS) is -$1.90. On average, analysts forecast that CCCC's EPS will be -$1.57 for 2024, with the lowest EPS forecast at -$1.70, and the highest EPS forecast at -$1.46. On average, analysts forecast that CCCC's EPS will be -$1.62 for 2025, with the lowest EPS forecast at -$1.90, and the highest EPS forecast at -$1.38. In 2026, CCCC's EPS is forecast to hit -$1.59 (min: -$2.24, max: -$1.33).

What is CCCC's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CCCC) forecast ROE is -47.71%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.